Medpace Hldgs (NASDAQ:MEDP) reported its Q4 earnings results on Monday, February 14, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate proceedings, and the week also witnessed presentations at conferences and a couple of initial public offerings.
Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2022-02-14. Here's what investors need to know before the announcement.
Analysts estimate that Medpace Hldgs will likely report an Earnings Per Share (EPS) of $1.25.
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the development 1,040 ART systems in Spain and Portugal.